Form D · Other Health Care

SilkTears, Inc.

Minneapolis, MN · CIK 0002007726

Offering snapshot reported Jul 18, 2024 · SEC filing

Reported sold: $3.56M
Investors reported: 10
Minimum accepted: $0
First sale: Dec 28, 2023

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$2,100,000 → $3,555,951
Reported investors2 → 10

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 18, 2024	Amendment	$3,555,951	$1,455,951vs Jan 12, 2024	10	SEC filing
Jan 12, 2024	Initial	$2,100,000	No comparison	2	SEC filing

Offering details

Securities: Equity, Option to acquire
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $264K (estimated)
Form D file number: 021-502253

Paid in the form of cash and stock options/warrants.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Douglas Hecker	None
Stuart Frizzell	None
Steve Faria	None
Paul Karpecki	None

Source: Form D, filed Jul 18, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Jared Cohen	Director
Brian Lawrence	Director
Jeffrey Poe	Executive
John Walborn	Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:

225 South Sixth Street, Suite 2900
Minneapolis, MN, 55402